Australia - English - Department of Health (Therapeutic Goods Administration)

mega lifesciences (australia) pty ltd - pelargonium sidoides, quantity: 6 mg/ml (equivalent: pelargonium sidoides, qty 30 mg/ml) - oral liquid - excipient ingredients: potassium sorbate; glycerol; sucrose; xanthan gum; flavour - treatment of acute, uncomplicated upper respiratory tract infections including common cold, acute bronchitis and acute sinusitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

mega lifesciences (australia) pty ltd - ferrous sulfate heptahydrate, quantity: 67.23 mg (equivalent: iron, qty 13.5 mg); haemoglobin, quantity: 500 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; magnesium stearate; iron oxide red; purified water; titanium dioxide; crospovidone; lactose monohydrate; pregelatinised maize starch; microcrystalline cellulose; calcium hydrogen phosphate dihydrate; polysorbate 80; purified talc; macrogol 4000; polyvinyl alcohol

Australia - English - Department of Health (Therapeutic Goods Administration)

mega lifesciences (australia) pty ltd - pelargonium sidoides, quantity: 30 mg (equivalent: pelargonium sidoides, qty 150 mg) - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; crospovidone; colloidal anhydrous silica; magnesium stearate; carnauba wax; titanium dioxide; indigo carmine; sunset yellow fcf; purified talc; allura red ac; polyvinyl alcohol; macrogol 3350; lecithin - treatment of acute,uncomplicated upper respiratory tract infections including common cold, acute bronchitis and acute sinusitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

mega lifesciences (australia) pty ltd - heavy magnesium oxide,pyridoxine hydrochloride,thiamine hydrochloride -

United States - English - NLM (National Library of Medicine)

international brand management inc - omega-3-acid ethyl esters (unii: d87ygh4z0q) (omega-3 fatty acids - unii:71m78end5s) - omega-3-acid ethyl esters 1 g in 1 g - each capsule contains 1 gram of omega-3 acid ethyl esters liquid concentrate consisting of at least 900 mg of omega-3 acid ethyl esters.

Australia - English - Department of Health (Therapeutic Goods Administration)

mega lifesciences (australia) pty ltd - dextromethorphan hydrobromide monohydrate, quantity: 10 mg; guaifenesin, quantity: 200 mg; pseudoephedrine hydrochloride, quantity: 30 mg - capsule, soft - excipient ingredients: propylene glycol; povidone; sorbitol; gelatin; carmoisine; macrogol 400; purified water; glycerol - for the temporary relief from nasal congestion and coughs associated with colds.

Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - zolpidem tartrate, quantity: 10 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; sodium starch glycollate type a; hypromellose; magnesium stearate; titanium dioxide; macrogol 400 - zolpidem tartrate is indicated for the short term treatment of insomnia in adults (see dosage and administration).

Australia - English - Department of Health (Therapeutic Goods Administration)

mega lifesciences (australia) pty ltd - glucosamine sulfate potassium chloride, quantity: 217.4 mg/g (equivalent: potassium chloride, qty 54.4 mg/g; equivalent: glucosamine sulfate, qty 163 mg/g); bovine chondroitin sulfate, quantity: 130.4 mg/g - powder - excipient ingredients: citric acid; brilliant blue fcf; glucose monohydrate; quinoline yellow; sucralose; sodium chloride; flavour - helps maintain/support joint cartilage health ; helps enhance/promote healthy joint function ; helps enhance/promote joint health ; helps enhance/improve/promote joint mobility

Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - duloxetine hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - duloxetine hydrochloride -